These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9871334)

  • 41. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
    Omri A; Ravaoarinoro M; Poisson M
    J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli.
    Fantin B; Ebert S; Leggett J; Vogelman B; Craig WA
    J Antimicrob Chemother; 1991 Jun; 27(6):829-36. PubMed ID: 1938689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The new aminoglycoside antibiotics.
    Fields BT
    J Ark Med Soc; 1976 Aug; 73(3):141-4. PubMed ID: 134018
    [No Abstract]   [Full Text] [Related]  

  • 44. [Influence of sub-mics of selected antibiotics on hydrophobic and adhering properties of Klebsiella pneumoniae strains isolated from urine samples].
    Sekowska A; Gospodarek E; Wróblewska J
    Med Dosw Mikrobiol; 2008; 60(4):297-302. PubMed ID: 19382601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D; Majtán V
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Aminoside sensitivity of bacteria isolated in 1984 at the military hospital complex in the Paris region].
    Meyran M; Buisson Y; Saliou P; Levagueresse R; Santiago M; Thabaut A
    Pathol Biol (Paris); 1987 May; 35(5):457-60. PubMed ID: 3302847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some properties of Plesiomonas shigelloides treated with aminoglycosides.
    Hostacká A; Ciznár I
    Folia Microbiol (Praha); 2003; 48(5):659-63. PubMed ID: 14976725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
    Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
    Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
    Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of amikacin on cytotoxic activity and hydrophobicity of Acinetobacter baumannii.
    Hostacká A; Kováciková Z
    Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):653-7. PubMed ID: 10702960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.
    Novelli A; Mazzei T; Fallani S; Cassetta MI; Conti S
    J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum bactericidal activity against Klebsiella pneumoniae in volunteers receiving increasing doses of tobramycin with or without cefamandole.
    Pascual-Lopez A; Lagast H; Klastersky J
    Int J Clin Pharmacol Res; 1987; 7(1):45-9. PubMed ID: 3294615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
    Majtán V; Hostacká A
    Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outer membrane proteins of Klebsiella pneumoniae after exposure to ciprofloxacin.
    Hostacká A; Karelová E
    Zentralbl Bakteriol; 1998 May; 287(4):343-6. PubMed ID: 9638864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene.
    Ko JH; Baek JY; Peck KR; Cho SY; Ha YE; Kim SH; Huh HJ; Lee NY; Kang CI; Chung DR; Song JH
    J Med Microbiol; 2017 Oct; 66(10):1448-1450. PubMed ID: 28893358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL].
    Wieczorek P; Sacha PT; Leszczyńska K; Jakoniuk P; Zalewska M
    Med Dosw Mikrobiol; 2006; 58(1):27-32. PubMed ID: 16871970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mathematical model of Klebsiella pneumoniae resistance to amikacin and gentamicin.
    Nicolelis MA; Massad E; Hutzler RU; Engel A; Rodrigues E; Bazzone JC; Tomida M
    Braz J Med Biol Res; 1987; 20(1):35-41. PubMed ID: 3318975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.